@ARTICLE{
author={Sacca Francesco,Barnett-Tapia C,Vu T,Peric Stojan Z,Phillips Glenn A,Zhao Sihui,Gelinas D,Chiroli Silvia,Verschuuren J},
year={2022},
title={Efgartigimod improved quality-of-life in gMG: a randomised, double-blinded, placebo-controlled, phase 3 trial (ADAPT)},
journal={EUROPEAN JOURNAL OF NEUROLOGY},
volume={29},
number={},
pages={240-240},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Skeie GO,Apostolski Slobodan A,Evoli A,Gilhus NE,Illa I,Harms L,Hilton-Jones D,Melms A,Verschuuren J,Horge HW},
year={2010},
title={Guidelines for treatment of autoimmune neuromuscular transmission disorders},
journal={EUROPEAN JOURNAL OF NEUROLOGY},
volume={17},
number={7},
pages={893-902},
document_type={Article},
} 

@ARTICLE{
author={Skeie GO,Apostolski Slobodan A,Evoli A,Gilhus NE,Hart IK,Harms L,Hilton-Jones D,Melms A,Verschuuren J,Horge HW},
year={2006},
title={Guidelines for the treatment of autoimmune neuromuscular transmission disorders},
journal={EUROPEAN JOURNAL OF NEUROLOGY},
volume={13},
number={7},
pages={691-699},
document_type={Article},
}